Isotretinoin is active in the initial management of acute pro-myelocytic leukemia

Pro-myelocytic acute leukemia (APL) is characterized by the proliferation of cells blocked at promyelocytic stage and ATRA is the choice of initial treatment because of the APL sensitivity to this compound. In this case study we report a 28-year-old man who presented to the Emergency Department with...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhaldy, Husain Y., Assiri, Ali M., Fatima, Sohaila, Owaidah, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426566/
https://www.ncbi.nlm.nih.gov/pubmed/32817817
http://dx.doi.org/10.1016/j.lrr.2020.100220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426566/
https://www.ncbi.nlm.nih.gov/pubmed/32817817
http://dx.doi.org/10.1016/j.lrr.2020.100220

Ejemplares similares